Table 1.
Whole LS cohort (N = 112) | Study population (responders) (N = 76) | |
---|---|---|
Age | ||
Median (range) | 49 (30–89) | 52 (30–82) |
Age at mutation testing | ||
Median | 38 (20–72) | 36 (22–65) |
Distribution of MMR genes | ||
MLH1 | 72 (64%) | 47 (62%) |
MSH2 | 32 (29%) | 22 (29%) |
MSH6 | 8 (7%) | 7 (9%) |
History of other cancer (Y/N) | ||
Y | 42 (38%) | 24 (33%) |
N | 70 (62%) | 49 (67%) |
Prophylactic surgery performed | ||
Y | 63 (56%) | 42 (68%) |
N | 49 (44%) | 24 (32%) |
LS Lynch syndrome, path_MMR pathogenic variant of DNA mismatch repair gene